tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
US Market

Cipher Pharmaceuticals (CPHRF) Income Statement

Compare
20 Followers

Cipher Pharmaceuticals Income Statement

Last quarter (Q4 2025), Cipher Pharmaceuticals's total revenue was $12.41M, an increase of 4.94% from the same quarter last year. In Q4, Cipher Pharmaceuticals's net income was $13.52M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 51.33M$ 33.36M$ 21.16M$ 20.68M$ 21.94M
Gross Profit
$ 33.77M$ 24.10M$ 17.09M$ 16.68M$ 18.26M
Operating Expenses
$ 16.97M$ 16.25M$ 5.56M$ 5.63M$ 6.45M
Depreciation and Amortization
$ 0.00$ 4.02M$ 1.23M$ 989.00K$ 701.00K
EBITDA
$ 16.80M$ 11.87M$ 11.53M$ 12.04M$ 13.66M
Operating Income
$ 16.80M$ 7.85M$ 11.53M$ 12.04M$ 11.82M
Other Income/Expenses
$ 661.38K$ -4.89M$ 1.15M$ -560.00K$ -2.00M
Pretax Income
$ 17.46M$ 2.96M$ 12.68M$ 11.48M$ 11.06M
Net Income
$ 27.81M$ 11.54M$ 20.38M$ 26.64M$ 7.76M
Per Share Metrics
Basic EPS
$ 1.09$ 0.46$ 0.80$ 1.06$ 0.29
Diluted EPS
$ 1.07$ 0.47$ 0.80$ 1.04$ 0.29
Weighted Average Shares Outstanding
25.48M 24.72M 25.48M 25.13M 26.60M
Weighted Average Shares Outstanding (Diluted)
25.99M 24.57M 25.42M 25.59M 26.83M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History